Kazia Therapeutics Ltd ADR Dividends
The next dividend date for Kazia Therapeutics Ltd ADR has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Kazia Therapeutics Ltd ADR (KZIA)
More About Kazia Therapeutics Ltd ADR
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3 that is in Phase I clinical trial to treat advanced solid tumors and ovarian cancer. The company has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, Sovargen Co., Ltd, and QIMR Berghofer Medical Research Institute. Kazia Therapeutics Limited was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Owning Kazia Therapeutics Ltd ADR Stock on the Dividend Date
If you own Kazia Therapeutics Ltd ADR stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Kazia Therapeutics Ltd ADR stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Kazia Therapeutics Ltd ADR stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Kazia Therapeutics Ltd ADR stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Kazia Therapeutics Ltd ADR dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Kazia Therapeutics Ltd ADR Dividends
You can contact us any time if you would like to ask questions about Kazia Therapeutics Ltd ADR dividends or anything else related to the stock market.